Recursion Pharma RXRX

HealthcareMarket cap $2B4 connections

Recursion uses AI and robotics to run millions of biology experiments simultaneously, generating datasets 1,000x larger than traditional drug discovery. Its Recursion OS platform has mapped how thousands of genetic perturbations affect cells. Nvidia invested $50M+ given the GPU compute requirements. Drug discovery at machine speed.

Explore Recursion Pharma on the interactive map Relationship timeline Find a path to another company

Suppliers 1

Companies that sell to Recursion Pharma

AmazonConsumer & Retail · $2.0TRecursion AWS cloud for massive biology compute

Partners 3

Strategic partnerships, joint products and alliances

NVIDIASemiconductors · $2.2TNVIDIA $50M+ investment in Recursion AI drug discovery
MerckHealthcare · $290BMerck collaborates on Recursion AI drug programs
AmgenHealthcare · $160BAI drug discovery

Other Healthcare companies

Eli Lilly UnitedHealth Novo Nordisk Johnson & Johnson AbbVie Merck AstraZeneca Thermo Fisher Novartis Abbott Labs

Embed this on your site

Show Recursion Pharma's network in an article or report - it updates as our data does.

<iframe src="https://vexmap.com/embed.html?co=RXRX" width="600" height="420" style="border:0;border-radius:12px;max-width:100%" title="Recursion Pharma on VexMap" loading="lazy"></iframe>

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.